China Universal Asset Management »

Mersana Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Mersana Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mersana Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mersana Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.8k 875 7.76

More positions owned by China Universal Asset Management

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Alphabet Inc-cl A Common Stock (GOOGL)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Meta Platforms Inc-class A Common Stock (META)
Tesla Common Stock (TSLA)
Amgen Common Stock (AMGN)
Alphabet Inc-cl C Common Stock (GOOG)
Vertex Pharmaceuticals Common Stock (VRTX)
Gilead Sciences Common Stock (GILD)
Proshares Ultra Gold Etp (UGL)
Netflix Common Stock (NFLX)
Spdr Gold Minishares Trust Etp (GLDM)

View all positions for China Universal Asset Management

Top funds holding Mersana Therapeutics

Nextech Invest
Alamea Verwaltungs GmbH
Bain Capital Life Sciences Investors
Schonfeld Strategic Advisors
Vanguard Group
Rock Springs Capital Management
Acadian Asset Management
Silverarc Capital Management
683 Capital Management
BlackRock
Renaissance Technologies
Millennium Management
5AM Venture Management
Mackenzie Financial
AQR Capital Management

View all funds holding Mersana Therapeutics